We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+11.45%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76M
AUM Growth
-$11.1M
(-13%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
147.28%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
408
New
159
Increased
53
Reduced
54
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$3.17M |
| 2 |
K
Kellanova
K
|
+$2.19M |
| 3 |
FL
Foot Locker
FL
|
+$2.04M |
| 4 |
General Mills
GIS
|
+$1.95M |
| 5 |
lululemon athletica
LULU
|
+$1.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$9.7M |
| 2 |
JPMorgan Chase
JPM
|
+$3.58M |
| 3 |
Gilead Sciences
GILD
|
+$3.38M |
| 4 |
Constellation Brands
STZ
|
+$2.74M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.66% |
| 2 | Consumer Staples | 16.16% |
| 3 | Consumer Discretionary | 9.31% |
| 4 | Communication Services | 3.38% |
| 5 | Materials | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
Unilever
UL
$134B
| $50K | 0.07% |
+17,778
| New | +$899K |
|
152
CALL
Church & Dwight Co
CHD
$23.2B
| $49K | 0.06% |
40,900
+16,800
| +70% | +$803K |
|
153
Infosys
INFY
$46.5B
| $49K | 0.06% |
+6,170
| New | +$46K |
|
154
PUT
Ulta Beauty
ULTA
$20.6B
| $47K | 0.06% |
+9,000
| New | +$2.46M |
|
|
155
CALL
lululemon athletica
LULU
$13.2B
| $46K | 0.06% |
+49,100
| New | +$3.23M |
|
156
Sprouts Farmers Market
SFM
$7.13B
| $46K | 0.06% |
+2,000
| New | +$39.2K |
|
157
PUT
TG Therapeutics
TGTX
$8.4B
| $46K | 0.06% |
+47,700
| New | +$342K |
|
|
158
CALL
General Mills
GIS
$20.3B
| $45K | 0.06% |
106,200
-12,200
| -10% | -$746K |
|
|
MDCO
159
PUT
DELISTED
Medicines Co
MDCO
| $44K | 0.06% |
+13,000
| New | +$593K |
|
160
PUT
Domino's
DPZ
$10.7B
| $43K | 0.06% |
32,200
+22,200
| +222% | +$3.98M |
|
161
CALL
Akamai
AKAM
$17.5B
| $42K | 0.06% |
+19,100
| New | +$1.25M |
|
|
FL
162
PUT
DELISTED
Foot Locker
FL
| $42K | 0.06% |
+28,300
| New | +$2.04M |
|
163
PUT
Coca-Cola
KO
$351B
| $42K | 0.06% |
60,500
+25,500
| +73% | +$1.06M |
|
|
SIOX
164
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $42K | 0.06% |
+1,188
| New | +$125K |
|
165
CALL
Autodesk
ADSK
$46.1B
| $41K | 0.05% |
+17,500
| New | +$1.46M |
|
166
CALL
Yelp
YELP
$1.44B
| $39K | 0.05% |
77,100
+18,000
| +30% | +$668K |
|
167
PUT
Kimberly-Clark
KMB
$36B
| $38K | 0.05% |
37,000
+10,000
| +37% | +$1.26M |
|
168
PUT
Monster Beverage
MNST
$95.4B
| $38K | 0.05% |
+45,000
| New | +$1.01M |
|
169
PUT
Papa John's
PZZA
$1.08B
| $38K | 0.05% |
27,000
+12,000
| +80% | +$976K |
|
|
AVXS
170
CALL
DELISTED
AveXis, Inc. Common Stock
AVXS
| $38K | 0.05% |
+17,200
| New | +$1.06M |
|
|
SAGE
171
PUT
DELISTED
Sage Therapeutics
SAGE
| $37K | 0.05% |
+19,300
| New | +$1.13M |
|
172
PUT
Apple
AAPL
$4.9T
| $35K | 0.05% |
+172,000
| New | +$5.66M |
|
|
ACOR
173
PUT
DELISTED
Acorda Therapeutics
ACOR
| $32K | 0.04% |
+500
| New | +$1.44M |
|
174
CALL
Amgen
AMGN
$198B
| $31K | 0.04% |
16,000
+1,000
| +7% | +$166K |
|
175
CALL
Mondelez International
MDLZ
$78.3B
| $31K | 0.04% |
78,200
+8,000
| +11% | +$355K |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q1 2017 Portfolio in Review
As of Q1 2017, FT Options held 408 positions worth $76M, down 13% from $87.1M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
FT Options deployed $112M of net new capital in Q1 2017, opening 159 new positions and adding to 53 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $9.7M trimmed.
- FT Options's largest Q1 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.
- FT Options added most to Kellanova in Q1 2017, an estimated $2.19M increase.
- FT Options's biggest Q1 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $9.7M.
- FT Options fully exited JPMorgan Chase in Q1 2017, selling an estimated $3.58M.
- FT Options's ten largest holdings make up 38% of its $76M portfolio in Q1 2017.
- FT Options opened 159 new positions and closed 131 in Q1 2017.
- FT Options's portfolio value fell 13% quarter-over-quarter to $76M.
Based on FT Options's 13F filing for Q1 2017, filed 12 May 2017.